publication venue for
- Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes 2023
- Simultaneous Cone Beam Computed Tomography (CBCT) Acquisition during Volumetric Modulated Arc Therapy (VMAT): A Comparison of Volume Delineation and Organ Position on Simultaneous and Peri-radiotherapy CBCT 2014
- A Simple Planning Software Model to Account for Linac Couch Attenuation 2011
- Volumetric Modulated Arc Therapy vs Intensity Modulated Radiotherapy for Three Dose Level Prostate Treatments 2011
- P15 The IMPORT Gold Seed Study: Evaluation of Tumour Bed Localisation and Image-guided Radiotherapy for Breast Cancer 2007
- An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Surveillance Strategies in Patients with Stage I, II, III or Resectable IV Melanoma Who Were Treated with Curative Intent. 36:243-253. 2024
- A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design. 36:e11-e19. 2024
- Organ and Function Preservation in Gastrointestinal Malignancies. 35:524-532. 2023
- Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study. 35:e182-e188. 2023
- Another Brick in the Wall … no More! Breaking the Sex Bias. 34:796-798. 2022
- Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review. 33:e599-e612. 2021
- Relationship of Urethral Dose and Genitourinary Toxicity Among Patients Receiving Vaginal High Dose Rate Interstitial Brachytherapy. 33:773-779. 2021
- Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study. 33:468-475. 2021
- Systemic Radiotherapy of Bone Metastases With Radionuclides. 33:98-105. 2021
- Smoking Cessation in Cancer Care: Myths, Presumptions and Implications for Practice. 32:400-406. 2020
- MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins. 31:479-485. 2019
- Barriers to Referral for Palliative Radiotherapy by Physicians: A Systematic Review. 31:e75-e84. 2019
- Response to: The Survival Time of 8376 Male Breast Cancer Patients. 30:818-819. 2018
- Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy. 30:658-666. 2018
- Use of Comprehensive Geriatric Assessment and Geriatric Screening for Older Adults in the Radiation Oncology Setting: A Systematic Review. 30:578-588. 2018
- Treatment Outcomes in Male Breast Cancer: A Retrospective Analysis of 161 Patients. 30:354-365. 2018
- Adjuvant Chemotherapy for Stage II and III Colon Cancer Following Complete Resection: A Cancer Care Ontario Systematic Review. 29:459-465. 2017
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline. 29:348-355. 2017
- Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data. 29:161-170. 2017
- Management of Early-stage Hodgkin Lymphoma: A Practice Guideline. 29:e5-e12. 2017
- Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline. 29:e13-e28. 2017
- Multidisciplinary Influence on Care of Lung Cancer Patients at the Time of Diagnosis: a Patient Survey. 28:667-667. 2016
- Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review. 28:550-567. 2016
- The Effectiveness of Group-based Self-management Programmes to Improve Physical and Psychological Outcomes in Patients with Cancer: a Systematic Review and Meta-analysis of Randomised Controlled Trials. 28:292-305. 2016
- Locoregional Treatment in Early Stage Breast Cancer: More Evidence and Yet More Questions?. 27:689-691. 2015
- Bortezomib in Multiple Myeloma: A Practice Guideline. 26:110-119. 2014
- Predicting 2-Year Survival for Radiation Regimens in Advanced Non-small Cell Lung Cancer. 25:697-705. 2013
- Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review. 25:406-430. 2013
- Systematic Chemotherapy for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma: A Systematic Review. 25:346-355. 2013
- Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer. 24:684-696. 2012
- The Canadian Association of Radiation Oncology Scope of Practice Guidelines for Lung, Liver and Spine Stereotactic Body Radiotherapy. 24:629-639. 2012
- Intensity-modulated Radiotherapy in the Treatment of Breast Cancer. 24:488-498. 2012
- Radionuclide Therapy in Neuroendocrine Tumours: A Systematic Review. 24:294-308. 2012
- Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence. 24:183-189. 2012
- High-intensity Focused Ultrasound for Prostate Cancer: a Systematic Review. 23:117-127. 2011
- Preoperative or Postoperative Therapy for Stage II or III Rectal Cancer: An Updated Practice Guideline. 22:265-271. 2010
- Management of Stage I Non-seminomatous Testicular Cancer: a Systematic Review and Meta-analysis. 22:17-26. 2010
- Management of Stage I Seminomatous Testicular Cancer: a Systematic Review. 22:6-16. 2010
- Organisational Standards for the Delivery of Intensity-modulated Radiation Therapy in Ontario. 21:192-203. 2009
- The Utility of Publicly Reported Cancer Treatment Wait Time Information for Patients and Health Care Providers. 21:218-225. 2009
- Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies. 20:763-768. 2008
- Improving Observer Variability in Target Delineation for Gastro-oesophageal Cancer—the Role of 18Ffluoro-2-deoxy-d-glucose Positron Emission Tomography/Computed Tomography. 20:631-638. 2008
- The role of interleukine-12 in protection induced by CpG ODN against Listeria monocytogenes in BALB/c and C57BL/6. 14:197-201. 2006
- Factors Influencing the Use of Single vs Multiple Fractions of Palliative Radiotherapy for Bone Metastases: A 5-Year Review. 17:430-434. 2005
- Prognostic factors in brain metastases: can we determine patients who do not benefit from whole-brain radiotherapy?. 16:332-338. 2004
- Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer:. 16:160-161. 2004
- A Consensus Development Approach to Define National Research Priorities in Bone Metastases: Proceedings from NCIC CTG Workshop. 15:496-499. 2003
- Radiation Induced Mucositis: Co-ordinating a Research Agenda. 15:473-477. 2003
- Supportive Care Management of Brain Metastases: What is Known and What We Need to Know. 15:429-434. 2003
- Treatment of the Internal Mammary Nodes in Early Breast Cancer: Back to the Future. 15:14-16. 2003
- Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer–a Meta-analysis. 14:203-212. 2002
- External Beam Radiotherapy: A Treatment Option for Massive Haemoptysis Caused by Mycetoma. 14:233-235. 2002
- Rare tumours of the cerebellopontine angle. 7:28-41. 1995
- A clinical audit of glottic cancer in Nova Scotia: A paradigm for effectiveness research. 6:14-23. 1994
- Fertility in patients treated with radiotherapy following orchidectomy for testicular seminoma. 6:377-380. 1994
- Phase I study of hyperfractionated whole brain irradiation (HWBI) in the treatment of primary cerebral lymphoma. 5:159-164. 1993
- A comparison of manual and remote afterloading in the treatment of carcinoma of the cervix: Increasing dose rate with a flexible applicator. 4:294-298. 1992
- Metastasis to the penis from malignant melanoma: Case report and review of the literature. 4:130-131. 1992
- Multifocal neurotoxicity during interleukin-2 therapy for malignant melanoma. 4:135-136. 1992
- Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy. 3:183-183. 1991
- Malignant lymphomatous polyposis: Diagnosis and response to chemotherapy. 2:230-234. 1990